Barcelona 2022

Browse: Pre-Congress Content Sunday, 04.09.2022 Monday, 05.09.2022 Tuesday, 06.09.2022		Monday, 14.11.2022 Tuesday, 15.11.2022 Wednesday, 16.11.2022 Thursday, 17.11.2022 Friday, 18.11.2022

Citations should be made in the following way: Authors. Title. Eur Respir J 2022; 60: Suppl. 66, abstract number.

Interstitial lung diseases

State of the art session
Chairs: K. Antoniou (Heraklion, Greece), K. Moor (Rotterdam, Netherlands), S. Harari (Milano (MI), Italy)
Aims: to present significant insights gained recently about many different forms of rare lung diseases, i.e cystic lung diseases (lymphangioleiomyomatosis), fibrosing lung diseases. To discuss new treatment options that have been licensed for different pulmonary complications of autoimmune diseases, which commonly affect the lungs; to provide an update about drug-induced lung diseases that are an important differential diagnosis of ILDs; to discuss challenges in diagnosis and treatment. to emphasize the importance of acute exacerbations which are one of the most debilitating complications of mainly fibrosing ILDs and are a neglected field.

Download all media

New trends in cystic lung diseases C. McCarthy (Dublin 4, Ireland)
Acute exacerbations of fibrosing ILDs: controversies and new insights M. Kreuter (Heidelberg, Germany)
Pulmonary manifestations in autoimmune diseases E. Bendstrup (Aarhus N, Denmark)
Drug-induced lung diseases: past, present and future P. Camus (Dijon, France)
Discussion and Q&A